Supernus says FDA grants tentative OK to drug
14:40 EDT 26 Jun 2012 | R&D Magazine
Shares of Supernus Pharmaceuticals Inc. more than doubled in price Tuesday after the specialty drugmaker said regulators have moved closer to granting final approval to its potential epilepsy treatment Trokendi XR.The Rockville, Md., company said th..
Original Article: Supernus says FDA grants tentative OK to drug
More From BioPortfolio on "Supernus says FDA grants tentative OK to drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
